Skip to main content


Martin Hall

Finance Director, OXGENE

OXGENE is growing so rapidly but still retains the energy and vibrancy of a new start-up.

Martin joined the company in November 2017 and has more than 30 years financial and general management experience in technology and IP-focused businesses. He specialises in leading and developing small technology organisations through periods of rapid growth, fund-raising and international expansion to exit events including trade sale or preparation for IPO. Prior to joining OXGENE, Martin’s most recent role was CFO of Warwick-based Allinea Software, culminating in the successful sale of the business with an average return to shareholders of 100 x net investment. Martin was integral to the successful acquisition of OXGENE by WuXi AppTec to become part of WuXi Advanced Therapies in early 2021.

Prior experience includes fourteen years as global Head of Finance of Oxfordshire-headquartered Sophos - during which time the business grew from £2 million turnover and 15 employees to over £100 million turnover and 1,100 employees. Martin qualified as a Chartered Accountant with Price Waterhouse in London and holds a MA degree in Economics from the University of Cambridge.

Martin appreciates the close community at OXGENE, valuing the lasting relationships that he has built with co-workers as well as the strong company culture. He views the acquisition of OXGENE as an overwhelmingly positive development, both for OXGENE to offer their technologies to the world and for the wider impact on the cell and gene therapy industry. Outside of work, Martin enjoys walking in the Cotswolds where he lives with his family.